Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

BioAge Labs, Inc. BIOA

Set alert

Price alert · BIOA

All alert types
5.87 USD -0.07 -1.18%

At close · Oct 30

5.87 0.00 0.00%

After hours · Oct 30, 4:00 PM ET

Bid
5.88 × 2
Ask
5.89 × 2
5.63 Day range 5.93
4.84 52-week range 25.10
YTD
-55.63%
1 year
-24.06%
Open
5.86
Prev close
5.94
Mkt cap
269.41M
Vol
801.36K
Avg vol
964.44K
EPS
-2.39
P/E
0.00
Div yield
0.00%
More statistics
Low
5.63
High
5.93
Forward P/E
-12.08
Beta
0.00
Short ratio
4.63
Inst. own
85.48%
Dividend
0.00
Ex-div date
Earnings
Nov 5, 2026
50-d avg
18.87
200-d avg
15.13
1y target
49.50

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for BIOA has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

4.86 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C+2 / 5 overall

  • DCF 4
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 4
  • P/E 1
  • P/B 2

Valuation

P/E -5.9×
FY 2022: -15.8×FY 2023: -9.8×FY 2024: -2.9×FY 2025: -5.9×
FY 2022 5y median -7.8× FY 2025
P/S 52.9×
FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 52.9×
FY 2022 5y median 0.0× FY 2025
P/B 1.7×
FY 2022: -5.6×FY 2023: -3.6×FY 2024: 0.6×FY 2025: 1.7×
FY 2022 5y median -1.5× FY 2025
P/FCF -5.8×
FY 2022: -17.2×FY 2023: -16.7×FY 2024: -4.0×FY 2025: -5.8×
FY 2022 5y median -11.2× FY 2025
EV/EBITDA -3.7×
FY 2022: -15.3×FY 2023: -11.8×FY 2024: 2.0×FY 2025: -3.7×
FY 2022 5y median -7.7× FY 2025
EV/Sales 32.5×
FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 32.5×
FY 2022 5y median 0.0× FY 2025
FCF Yield -17.3%
FY 2022: -5.8%FY 2023: -6.0%FY 2024: -25.0%FY 2025: -17.3%
FY 2022 5y median -11.7% FY 2025

Profitability

Gross Margin 100.0%
FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 100.0%
FY 2022 5y median 0.0% FY 2025
Operating Margin -1031.5%
FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: -1031.5%
FY 2022 5y median 0.0% FY 2025
Net Margin -896.1%
FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: -896.1%
FY 2022 5y median 0.0% FY 2025
ROE -29.6%
FY 2022: 35.3%FY 2023: 36.8%FY 2024: -22.0%FY 2025: -29.6%
FY 2022 5y median 6.6% FY 2025
ROIC -33.4%
FY 2022: -175.4%FY 2023: -377.9%FY 2024: -23.2%FY 2025: -33.4%
FY 2022 5y median -104.4% FY 2025
ROA -27.3%
FY 2022: -139.7%FY 2023: -246.3%FY 2024: -19.8%FY 2025: -27.3%
FY 2022 5y median -83.5% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2022 FY 2025
Operating Income -18.7%
FY 2022: 0.0%FY 2023: -21.1%FY 2024: -61.6%FY 2025: -18.7%
FY 2022 FY 2025
EPS (diluted) -13.1%
FY 2022: 0.0%FY 2023: -61.2%FY 2024: -5.9%FY 2025: -13.1%
FY 2022 FY 2025
Free Cash Flow -58.7%
FY 2022: 0.0%FY 2023: -3.4%FY 2024: -38.3%FY 2025: -58.7%
FY 2022 FY 2025

Financial Health

Current Ratio 14.2×
FY 2022: 4.8×FY 2023: 0.4×FY 2024: 12.9×FY 2025: 14.2×
FY 2022 5y median 8.8× FY 2025
Quick Ratio 14.2×
FY 2022: 4.8×FY 2023: 0.4×FY 2024: 12.9×FY 2025: 14.2×
FY 2022 5y median 8.8× FY 2025
Debt / Equity 0.0×
FY 2022: -0.0×FY 2023: -0.3×FY 2024: 0.0×FY 2025: 0.0×
FY 2022 5y median -0.0× FY 2025
Net Debt / EBITDA 2.3×
FY 2022: 0.6×FY 2023: -0.6×FY 2024: 5.0×FY 2025: 2.3×
FY 2022 5y median 1.5× FY 2025
Interest Coverage -133×
FY 2022: -166×FY 2023: -6.2×FY 2024: -33.0×FY 2025: -133×
FY 2022 5y median -83.1× FY 2025

Dividends

Dividend Yield 0.0%
FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2022 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2022 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31